Clinical Trial Update: An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018 [Phase 3]

View source ↗

Summary

This document announces an extension of the Phase 3 trial of istradefylline for Parkinson's disease in patients who completed prior studies. It indicates contin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Nourianz (istradefylline)

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED